{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T05:09:31Z","timestamp":1782364171912,"version":"3.54.5"},"reference-count":51,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"26","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,6]]},"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>To assess the hypothesis if tocilizumab (TCZ) is effective on disease activity, and also its effect in fatigue and other clinical and psychological disease-related factors in patients with rheumatoid arthritis (RA) treated with TCZ.<\/jats:p>\n            <jats:p>A 24-week, multicenter, prospective, observational study in patients with moderate to severe RA receiving TCZ after failure or intolerance to disease-modifying antirheumatic drugs or tumor necrosis factor-alpha was conducted.<\/jats:p>\n            <jats:p>Of the 122 patients included, 85 were evaluable for effectiveness (85% female, 51.9\u200a\u00b1\u200a12.5 years, disease duration 8.7\u200a\u00b1\u200a7.4 years). Mean change in C-reactive protein level from baseline to week 12 was \u221211.2\u200a\u00b1\u200a4.0 (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.001). Mean Disease Activity Index score (DAS28) decreased from 5.5\u200a\u00b1\u200a1.0 at baseline to 2.7\u200a\u00b1\u200a1.3 (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.001) at week 24. Mean change in Functional Assessment of Chronic Illness Therapy score was \u22125.4\u200a\u00b1\u200a11.2 points at week 24. Multiple regression analysis showed that the improvement in DAS28, sleep, and depression explained 56% and 47% of fatigue variance at week 12 and 24, respectively.<\/jats:p>\n            <jats:p>Tocilizumab is effective in reducing disease activity and results in a clinically significant improvement in fatigue, pain, swollen joint count, morning stiffness, sleepiness, depression, and DAS28; the last 3 were specifically identified as factors explaining fatigue variance with the use of TCZ in RA patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000015947","type":"journal-article","created":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T13:22:52Z","timestamp":1561728172000},"page":"e15947","source":"Crossref","is-referenced-by-count":29,"title":["Correlation of fatigue with other disease related and psychosocial factors in patients with rheumatoid arthritis treated with tocilizumab"],"prefix":"10.1097","volume":"98","author":[{"given":"H\u00e9ctor","family":"Corominas","sequence":"first","affiliation":[{"name":"Rheumatology Department, Hospital Sant Joan Desp\u00ed Moises Broggi"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cayetano","family":"Alegre","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Hospital Vall d\u2019Hebr\u00f3n"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Narv\u00e1ez","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Hospital Universitario de Bellvitge, L\u2019Hospitalet de Llobregat, Barcelona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Marras","family":"Fern\u00e1ndez-Cid","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Hospital Universitario Virgen de la Arrixaca, Murcia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicen\u00e7","family":"Torrente-Segarra","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Hospital General de l\u2019Hospitalet, L\u2019Hospitalet de Llobregat"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel Rodr\u00edguez","family":"G\u00f3mez","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Complejo Hospitalario Cristal Pi\u00f1or, Ourense"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Maceiras","family":"Pan","sequence":"additional","affiliation":[{"name":"Complejo Hospitalario Arquitecto Marcide-Profesor Novoa Santos, A Coru\u00f1a"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa Mar\u00eda","family":"Morl\u00e0","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Xarxa Sanitaria i Social de Santa Tecla, Tarragona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando Jos\u00e9 Rodr\u00edguez","family":"Mart\u00ednez","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Hospital General Universitario Santa Mar\u00eda del Rosell, Cartagena, Murcia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoni","family":"G\u00f3mez-Centeno","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Corporaci\u00f3 Sanit\u00e0ria Parc Taul\u00ed, Barcelona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Losada","family":"Ares","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Hospital da Costa Burela, Burela, Lugo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roc\u00edo Gonz\u00e1lez","family":"Molina","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Hospital Rafael M\u00e9ndez, Lorca, Murcia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia Paredes","family":"Gonz\u00e1lez-Albo","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Hospital Universitari Sant Joan de Reus, Tarragona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Dalmau-Carol\u00e0","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Cl\u00ednica Girona, Girona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"P\u00e9rez-Garc\u00eda","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Hospital de Mollet, Mollet del Valles, Barcelona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ceferino Barbaz\u00e1n","family":"\u00c1lvarez","sequence":"additional","affiliation":[{"name":"Hospital Xeral Cies, Vigo, Pontevedra"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliana","family":"Ercole","sequence":"additional","affiliation":[{"name":"Medical Department, Roche Farma S.A., Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria \u00c1ngeles","family":"Terrancle","sequence":"additional","affiliation":[{"name":"Medical Department, Roche Farma S.A., Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230914","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/art.21450","article-title":"Patients\u2019 perceptions of fatigue in rheumatoid arthritis: overwhelming, uncontrollable, ignored","volume":"53","author":"Hewlett","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R2-20230914","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1093\/rheumatology\/kep287","article-title":"Fatigue is a reliable, sensitive and unique outcome measure in rheumatoid arthritis","volume":"48","author":"Minnock","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"R3-20230914","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1093\/rheumatology\/keg281","article-title":"Women with established rheumatoid arthritis perceive pain as the predominant impairment of health status","volume":"42","author":"Minnock","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"R4-20230914","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1093\/rheumatology\/kel021","article-title":"Fatigue in rheumatoid arthritis reflects pain, not disease activity","volume":"45","author":"Pollard","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"R5-20230914","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2702.2007.02082.x","article-title":"Persistent severe fatigue in patients with rheumatoid arthritis","volume":"16","author":"Repping-Wuts","year":"2007","journal-title":"J Clin Nurs"},{"key":"R6-20230914","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1093\/rheumatology\/keq043","article-title":"Physical and psychosocial correlates of severe fatigue in rheumatoid arthritis","volume":"49","author":"van","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"R7-20230914","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/rheumatology\/kep367","article-title":"A comparison of fatigue correlates in rheumatoid arthritis and osteoarthritis: disparity in associations with disability, anxiety and sleep disturbance","volume":"49","author":"Stebbings","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"R8-20230914","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1080\/13548500701796931","article-title":"Predictors of fatigue over 1 year among people with rheumatoid arthritis","volume":"13","author":"Treharne","year":"2008","journal-title":"Psychol Health Med"},{"key":"R9-20230914","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/acr.21949","article-title":"Fatigue and factors related to fatigue in rheumatoid arthritis: a systematic review","volume":"65","author":"Nikolaus","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R10-20230914","first-page":"24","article-title":"Anemia versus disease activity as cause of fatigue in rheumatoid arthritis","volume":"35","author":"Escobar","year":"2010","journal-title":"Acta Reumatol Port"},{"key":"R11-20230914","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1093\/rheumatology\/37.10.1042","article-title":"Fatigue in rheumatoid arthritis: the role of self-efficacy and problematic social support","volume":"37","author":"Riemsma","year":"1998","journal-title":"Br J Rheumatol"},{"key":"R12-20230914","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.3899\/jrheum.090561","article-title":"Is fatigue an inflammatory variable in rheumatoid arthritis (RA)? Analyses of fatigue in RA, osteoarthritis, and fibromyalgia","volume":"36","author":"Bergman","year":"2009","journal-title":"J Rheumatol"},{"key":"R13-20230914","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.3899\/jrheum.111068","article-title":"A multidimensional model of fatigue in patients with rheumatoid arthritis","volume":"39","author":"Nicassio","year":"2012","journal-title":"J Rheumatol"},{"key":"R14-20230914","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1093\/rheumatology\/keq282","article-title":"Fatigue in rheumatoid arthritis: time for a conceptual model","volume":"50","author":"Hewlett","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"R15-20230914","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/rheumatology\/ker162","article-title":"Effect of biotherapies on fatigue in rheumatoid arthritis: a systematic review of the literature and meta-analysis","volume":"51","author":"Chauffier","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"R16-20230914","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/art.27221","article-title":"Tocilizumab in systemic lupus erythematosus: data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation study","volume":"62","author":"Illei","year":"2010","journal-title":"Arthritis Rheum"},{"key":"R17-20230914","first-page":"259","article-title":"Treatment of severe rheumatoid arthritis by anti-interleukin 6 monoclonal antibody","volume":"20","author":"Wendling","year":"1993","journal-title":"J Rheumatol"},{"key":"R18-20230914","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1056\/NEJM199505183322008","article-title":"The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation","volume":"332","author":"Chrousos","year":"1995","journal-title":"N Engl J Med"},{"key":"R19-20230914","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1093\/rheumatology\/keq454","article-title":"Biological mechanisms of chronic fatigue","volume":"50","author":"Norheim","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"R20-20230914","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/art.1780380107","article-title":"Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis","volume":"38","author":"Prevoo","year":"1995","journal-title":"Arthritis Rheum"},{"key":"R21-20230914","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/art.1780390105","article-title":"Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization\/International League Against Rheumatism Criteria","volume":"39","author":"van Gestel","year":"1996","journal-title":"Arthritis Rheum"},{"key":"R22-20230914","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1477-7525-1-79","article-title":"The Functional Assessment of Chronic Illness Therapy (FACIT) measurement system: properties, applications, and interpretation","volume":"1","author":"Webster","year":"2003","journal-title":"Health Qual Life Outcomes"},{"key":"R23-20230914","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","article-title":"An inventory for measuring depression","volume":"4","author":"Beck","year":"1961","journal-title":"Arch Gen Psychiatry"},{"key":"R24-20230914","first-page":"249","article-title":"Adaptaci\u00f3n espa\u00f1ola del Inventario para la Depresi\u00f3n de Beck-II (BDI-II): Propiedades psicom\u00e9tricas en poblaci\u00f3n general","volume":"14","author":"Sanz","year":"2014","journal-title":"Cl\u00ednica y Salud"},{"key":"R25-20230914","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0300-2896(15)30037-5","article-title":"[Validation of the Spanish version of the Epworth Sleepiness Scale in patients with a sleep apnea syndrome]","volume":"35","author":"Chiner","year":"1999","journal-title":"Arch Bronconeumol"},{"key":"R26-20230914","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1136\/ard.2010.139725","article-title":"Effectiveness and safety of the interleukin 6-receptor antagonist tocilizumab after 4 and 24 weeks in patients with active rheumatoid arthritis: the first phase IIIb real-life study (TAMARA)","volume":"70","author":"Burmester","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"R27-20230914","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1136\/ard.2008.092932","article-title":"IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial","volume":"67","author":"Emery","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"R28-20230914","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1002\/art.23940","article-title":"Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: the tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study","volume":"58","author":"Genovese","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"(Suppl 2)","key":"R29-20230914","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/ar1916","article-title":"Interleukin-6: discovery of a pleiotropic cytokine","volume":"8","author":"Kishimoto","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"R30-20230914","doi-asserted-by":"crossref","first-page":"e98202","DOI":"10.1371\/journal.pone.0098202","article-title":"Increase of hemoglobin levels by anti-IL-6 receptor antibody (tocilizumab) in rheumatoid arthritis","volume":"9","author":"Hashimoto","year":"2014","journal-title":"PLoS One"},{"key":"R31-20230914","doi-asserted-by":"crossref","first-page":"R204","DOI":"10.1186\/ar4397","article-title":"Effect of tocilizumab on haematological markers implicates interleukin-6 signalling in the anaemia of rheumatoid arthritis","volume":"15","author":"Isaacs","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"R32-20230914","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1093\/rheumatology\/kes131","article-title":"Improvements in health-related quality of life after treatment with tocilizumab in patients with rheumatoid arthritis refractory to tumour necrosis factor inhibitors: results from the 24-week randomized controlled RADIATE study","volume":"51","author":"Strand","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"R33-20230914","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1002\/1529-0131(200007)43:7<1478::AID-ANR10>3.0.CO;2-M","article-title":"Determining minimally important changes in generic and disease-specific health-related quality of life questionnaires in clinical trials of rheumatoid arthritis","volume":"43","author":"Kosinski","year":"2000","journal-title":"Arthritis Rheum"},{"key":"R34-20230914","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.3899\/jrheum.081175","article-title":"Reevaluation of the role of duration of morning stiffness in the assessment of rheumatoid arthritis activity","volume":"36","author":"Khan","year":"2009","journal-title":"J Rheumatol"},{"key":"R35-20230914","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.jpsychores.2005.09.011","article-title":"Depression in rheumatoid arthritis patients: demographic, clinical, and psychological predictors","volume":"60","author":"Covic","year":"2006","journal-title":"J Psychosom Res"},{"key":"R36-20230914","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1093\/rheumatology\/kep170","article-title":"Depression in RA patients treated with anti-TNF is common and under-recognized in the rheumatology clinic","volume":"48","author":"Hider","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"R37-20230914","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1136\/ard.2007.086561","article-title":"Overnight variations in cortisol, interleukin 6, tumour necrosis factor alpha and other cytokines in people with rheumatoid arthritis","volume":"68","author":"Perry","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"R38-20230914","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/art.22368","article-title":"Circadian rhythms in rheumatoid arthritis: implications for pathophysiology and therapeutic management","volume":"56","author":"Straub","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"(suppl 5)","key":"R39-20230914","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/rheumatology\/kes113","article-title":"Understanding the dynamics: pathways involved in the pathogenesis of rheumatoid arthritis","volume":"51","author":"Choy","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"R40-20230914","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/RHU.0000000000000073","article-title":"Assessment of fatigue in rheumatoid arthritis (by Functional Assessment of Chronic Illness Therapy-Fatigue score) and its relation to disease activity and anemia","volume":"20","author":"Singh","year":"2014","journal-title":"J Clin Rheumatol"},{"key":"R41-20230914","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bbi.2007.06.013","article-title":"Chronic stress and regulation of cellular markers of inflammation in rheumatoid arthritis: implications for fatigue","volume":"22","author":"Davis","year":"2008","journal-title":"Brain Behav Immun"},{"key":"R42-20230914","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.3899\/jrheum.090157","article-title":"Fibromyalgia is common and adversely affects pain and fatigue perception in North Indian patients with rheumatoid arthritis","volume":"36","author":"Dhir","year":"2009","journal-title":"J Rheumatol"},{"key":"R43-20230914","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1002\/1529-0131(199812)41:12<2230::AID-ART19>3.0.CO;2-D","article-title":"Predictors of subjective fatigue among individuals with rheumatoid arthritis","volume":"41","author":"Huyser","year":"1998","journal-title":"Arthritis Rheum"},{"key":"R44-20230914","doi-asserted-by":"crossref","first-page":"904","DOI":"10.2340\/16501977-0444","article-title":"Factors related to fatigue in women and men with early rheumatoid arthritis: the Swedish TIRA study","volume":"41","author":"Thyberg","year":"2009","journal-title":"J Rehabil Med"},{"key":"R45-20230914","doi-asserted-by":"crossref","first-page":"R83","DOI":"10.1186\/ar3353","article-title":"Pain persists in DAS28 rheumatoid arthritis remission but not in ACR\/EULAR remission: a longitudinal observational study","volume":"13","author":"Lee","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"R46-20230914","first-page":"1407","article-title":"The prevalence and meaning of fatigue in rheumatic disease","volume":"23","author":"Wolfe","year":"1996","journal-title":"J Rheumatol"},{"key":"R47-20230914","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1093\/rheumatology\/keu398","article-title":"Sarzi-Puttini R Quality of life and unmet needs in patients with inflammatory arthropathies: results from the multicentre, observational RAPSODIA study","volume":"54","author":"Giacomeli","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"R48-20230914","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3109\/s10165-008-0125-1","article-title":"Study of active controlled tocilizumab monotherapy for rheumatoid arthritis patients with an inadequate response to methotrexate (SATORI): significant reduction in disease activity and serum vascular endothelial growth factor by IL-6 receptor inhibition therapy","volume":"19","author":"Nishimoto","year":"2009","journal-title":"Mod Rheumatol"},{"key":"R49-20230914","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/ard.2008.092866","article-title":"Long-term safety and efficacy of tocilizumab, an anti-IL-6 receptor monoclonal antibody, in monotherapy, in patients with rheumatoid arthritis (the STREAM study): evidence of safety and efficacy in a 5-year extension study","volume":"68","author":"Nishimoto","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"R50-20230914","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0140-6736(08)60453-5","article-title":"Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial","volume":"371","author":"Smolen","year":"2008","journal-title":"Lancet"},{"key":"R51-20230914","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.autrev.2017.07.012","article-title":"International consensus: what else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)? The unmet needs and the clinical grey zone in autoimmune disease management","volume":"16","author":"Giacomelli","year":"2017","journal-title":"Autoimmun Rev"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00005792-201906280-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T22:17:42Z","timestamp":1694729862000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201906280-00011"}},"subtitle":["ACT-AXIS study"],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":51,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000015947","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6]]}}}